WHO ICTRP trial

Evaluation of the effect of probiotics in preventing low anterior resection…

IRCT20210704051784N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT20210704051784N1
Public title Evaluation of the effect of probiotics in preventing low anterior resection syndrome
Scientific title Evaluation of the effect of probiotics in preventing lower rectal resection syndrome in patients with rectal cancer who have undergone lower anterior rectal resection
Primary sponsor Tehran University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Countries Iran (Islamic Republic of)
Conditions Patients with rectal cancer whose adenocarcinoma is pathologically proven and indicated for anterior resection.. Malignant neoplasm of colon, unspecified;C18.9
Interventions Intervention 1: Intervention group: Multilateral probiotics in the form of LactoCare capsules made by Zist-Takhmir Company will be given to patients every 12 hours (after lunch and after dinner) for 4 weeks. Participants will be given the…
Registration date Oct 26, 2021
Target size 180
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations